Mar 15 |
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Mar 1 |
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp
|
Feb 26 |
Pulmonx Announces Treatment of the First Patient with the AeriSealĀ® System in CONVERT II Pivotal Trial
|
Feb 24 |
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results
|
Feb 23 |
Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes
|
Feb 23 |
Analyst Ratings For Pulmonx
|
Feb 23 |
Pulmonx Full Year 2023 Earnings: Beats Expectations
|
Feb 22 |
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript
|
Feb 22 |
Q4 2023 Pulmonx Corp Earnings Call
|
Feb 22 |
Pulmonx Corporation 2023 Q4 - Results - Earnings Call Presentation
|